MRI study to help diagnose amyotrophic lateral sclerosis (ALS)
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial uses a special MRI scan to help diagnose ALS by looking at signs in both nerve pathways. If you’re being evaluated for ALS, it may help doctors confirm the diagnosis sooner and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form (or your legal representative can if needed).
- Your doctors suspect ALS based on accepted diagnostic standards (possible, probable, or defined).
- Your exam suggests involvement of the upper motor nerves (the brain/spinal cord side).
- Your testing suggests involvement of the lower motor nerves (the peripheral/nerve side), using nerve/electrical tests.
- You can safely have an MRI scan (no MRI safety conflicts).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses MRI scans to look for “imaging biomarkers” (scan patterns that may help track ALS). It may help researchers better understand disease changes over time and how ALS progresses.
This study uses MRI brain scans to understand how ALS affects the brain over time. It may help researchers develop better ways to measure the disease.
This study measures how well your nerves and muscles work together to see if it can serve as an early sign (a “biomarker”) of ALS. It may help doctors track ALS more accurately, especially in people who already seem to have ALS based on nerve testing.
This study tests a device called Myolex mScan that measures muscle health non-invasively in people with ALS. It aims to see if this can be a useful biomarker to track the disease progression.
This study tests whether special MRI scans can help evaluate neuromuscular (muscle/nerve) diseases. It may help doctors better assess muscle involvement and support diagnosis and evaluation.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
Hear when a new Amyotrophic Lateral Sclerosis With Dementia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.